Endocrine response to step-up microdose GnRH agonist.
- Author:
Su Kyoung KIM
1
;
Hyo Jung KIM
;
Jin Yong LEE
;
Seo Yoo HONG
;
Jung Hwan SHIN
;
Cheol Hong PARK
;
Eun Joo PARK
;
Yong Soo SEO
;
Won Il PARK
Author Information
1. Department of Obstetrics and Gynecology, Eulji University School of Medicine, Seoul, Korea. pwi3110@eulji.or.kr
- Publication Type:Original Article
- Keywords:
GnRH agonist;
Microdose;
FSH;
LH;
Estradiol
- MeSH:
Corpus Luteum;
Estradiol;
Female;
Gonadotropin-Releasing Hormone*;
Gonadotropins;
Humans;
Progesterone;
Testosterone;
Triptorelin Pamoate
- From:Korean Journal of Obstetrics and Gynecology
2006;49(11):2347-2355
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this study was to evaluate the endocrine response to step-up microdose GnRH agonist. METHODS: Administration of triptorelin acetate was initiated from 2 mg and gradually increased to 50 mg during 6-day period to five normal menstruating women. Serum FSH, LH, and estradiol levels were serially measured for 6 days. The same set of experiment was duplicated after taking oral contraceptive for 3 weeks. Serum testosterone and progesterone levels were measured on day 1 and day 5 of experiment. RESULTS: The flare of gonadotropin continued for 6 days. When subjects were pretreated with oral contraceptive, serum FSH levels 4 hrs after GnRH agonist injection were 17.35+/-7.88 mIU/mL, 11.26+/-4.81 mIU/mL, and 9.60+/-4.08 mIU/mL for day 1, 2, and 3 respectively. The FSH levels were not statistically different when pretreatment with oral contraceptive was not applied. The level of serum LH was significantly lower in the cycle, which was pretreated by oral contraceptive (32.13+/-9.61 mIU/mL vs. 14.12+/-5.63 mIU/mL for day 1, 28.95+/-3.09 mIU/mL vs. 15.76+/-9.92 mIU/mL for day 2, and 24.45+/-2.52 mIU/mL vs. 16.86+/-8.56 mIU/mL for day 3). The sign of corpus luteum rescue was found in 2 out of 5 subjects only in non-treated cycle. CONCLUSION: Step-up microdose GnRH agonist protocol could induce persistent gonadotropin flare for 6 days and this regimen could be applied in controlled ovarian hyperstimulation especially for poor responders. The pretreatment with oral contraceptive is necessary to prevent supraphysiologic LH elevation and corpus luteum rescue.
